comparemela.com
Home
Live Updates
Astellas to accelerate ocular disease therapies via $5.9b ac
Astellas to accelerate ocular disease therapies via $5.9b ac
Astellas to accelerate ocular disease therapies via $5.9b acquisition
A $5.9 billion acquisition of biotech Iveric Bio by Astellas is set to accelerate development of treatments for blinding retinal diseases.
Related Keywords
Pravinu Dugel ,
Prashant Khadayate ,
Astellas Pharma ,
Naoki Okamura ,
Iveric Bio ,
Berry Merger Sub Inc ,
Drug Administration ,
Astellas Us Holding Inc ,
Globaldata Pharma Intelligence Center ,
Iveric Bio Inc ,
Pharma Analyst ,
Avacincaptad Pegol ,
Age Related Macular Degeneration ,
Pharma Intelligence ,
Berry Merger Sub ,